EVONETIX develops technology for gene synthesis, aiming to contribute to the biology revolution.

EVONETIX

We are a Cambridge-based company developing a radically different approach to gene synthesis. Our desktop DNA synthesis platform will provide the ability to synthesise DNA at unprecedented accuracy, scale and speed, accelerating scientists'​ ability to use synthetic biology on a scale not currently possible. 

Innovate UK

Cambridge Consultants

Morningside Group

DCVC

Molten Ventures

Foresite Capital

Providence Investment Company Limited

Page One Ventures

Civilization Ventures

Evonetix Ltd

We're developing a novel silicon array that actively controls #DNAsynthesis, gene assembly and error correction at thousands of discrete sites across its surface. 

Our technology aims to put ultra-parallel #DNA preparation in the hands of researchers, enabling faster turn around and iteration at a scale currently only available in major service centres.

Gene synthesis will turn from a major bottleneck into the opportunity to drive forward the scope and ambition of #syntheticbiology.

Take a look at how it works: https://lnkd.in/gx-qX53v

Engineering biology is already shaping the world for the better, but a transformation in gene synthesis capabilities is needed before it can reach its potential. Our mission is to ignite the #engineeringbiology revolution by putting a gene foundry in every lab.  
 
Find out more below. 
www.evonetix.com

#sytheticbiology #DNA

Next week, our team will be attending the Synthetic and Engineering Biology British-Swiss Summit – a collaborative venture between academics and industry leaders to discuss how we can address healthcare and environmental challenges. 

This year’s summit includes an exciting programme of presentations from the latest advances in cell engineering to scale-up in bioprocessing and AI-driven solutions.

Check out the full agenda here: https://rb.gy/6btcev

#SynBio #EngineeringBiology #GeneSynthesis

Great to meet up with friends and colleagues in the synthetic biology space at this year’s SynBioBeta.
 
Thanks to the BioIndustry Association (BIA) for organising the UK Pavilion, showcasing the great companies shaping synthetic and engineering biology in the UK.
 
Find out more here: https://rb.gy/15dvft
 
#EngineeringBiology #SyntheticBiology #DNA

We’ll be in San Jose for #SynBioBeta2024 next week, joining industry leaders to discuss the transformative nature of synthetic biology and how it can revolutionize healthcare and other industries.
 
With sessions exploring the crucial role of gene synthesis in DNA-driven innovations, from treating disease to addressing some of the challenges presented by the planet, and the importance of biosecurity as the world of synthetic biology is rapidly expanding.
 
See the full agenda here: https://rb.gy/i5kpgr
 
#EngineeringBiology #SyntheticBiology #GeneSynthesis #DNA

We're looking forward to attending SynBioBeta next month as part of BioIndustry Association (BIA)’s UK Pavilion, alongside a network of industry leaders who are committed to using biology to build a better world. 
 
From engineers to investors, innovators, and entrepreneurs, The Global Synthetic Biology Conference gathers a broad range of individuals who share a passion for biological engineering to discuss the industry's latest innovations and cutting-edge technologies and how they are addressing some of the world's greatest challenges.
 
Find out more here: https://rb.gy/hzei35
 
#EngineeringBiology #SyntheticBiology #Sustainability

Amazon Virginia Region

Bamboo HR

Founder and Chief Technology Officer

Matthew Hayes

Vice President of Finance

Malcolm Gates

VP Research and Development

Matthew Hill

Vice President of Product

Mike Daniels

Vice President of Science and Applications

Raquel Sanches-Kuiper

Marketing Communications Manager

Clare Whitewoods

Non Executive Chair

Paul Beastall

Senior Scientist

Anke Husmann

Staff Engineer

Blair Kirkpatrick

Business Management

Colin McCracken

Joseph Brennan

Chief Scientific Officer

Ray Edgson

Director

Chief Executive Officer

Yuyin Qi

United Kingdom Life Science Companies

Europe, Middle East, and Africa (EMEA) Biotechnology Companies with Early Stage Venture Funding

DCVC Portfolio Companies

Biotechnology Companies With Less Than $10M in Revenue (Top 10K)

evonetix is a  new spin-out company that is currently incubating in the centre of the world-renowned Cambridge cluster of high-tech and life science organisations. We are seeking to develop and commercialise a new approach to the synthesis of DNA to facilitate the fast-emerging and exciting field of synthetic biology. 
By employing novel techniques we are able to advance DNA synthesis to levels never before seen. Our engineering team has decades of experience developing high integrity automated systems. Our high calibre team brings together expertise from across the scientific and engineering disciplines.

Series B - evonetix

Grant - evonetix

Series A - evonetix

Computer and Software Products and Electrical and Scientific Products

Little Chesterford

Essex

United Kingdom

Europe

evonetix

Back to the future as Diston takes CEO role in Evonetix rebuild

Persistent invests in EcoNetix

The 150 game-changing tech deals of 2023

Evonetix and Analog Devices Inc to progress revolutionary gene synthesis platform

Evonetix Announces Agreement for Revolutionary Gene Synthesis Platform with Analog Devices

Hong Kong

Asia

United States

North America

Cambodia

HTML5

Amazon Route 53

GlobalSign

HubSpot Forms

Adobe Fonts

Apache Server

Comodo PositiveSSL Certificates

Wordpress

Google Maps API

Google Analytics

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Sep 4, 2024 5:47 AM	73265919
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Sep 4, 2024 5:51 AM	4df363f5
company summary	general
signals	general
crunchbase trigger	general	Oct 29, 2024 5:10 PM	5b3d44f7
crunchbase profile	general	Oct 30, 2024 10:20 AM	d7b26e9c
li profile	general	Sep 4, 2024 5:47 AM	08267168
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	fcf580a8
peers	general	Sep 4, 2024 5:47 AM	67bc0e88
news basic	general	Sep 4, 2024 5:47 AM	c7123966
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

EVON

COM:EVONETIX

EVONETIX